Stephen R. Zeldenrust

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

Nelson Leung, Morie A. Gertz, Stephen R. Zeldenrust et al. · Kidney International · 2008 · 216 citations · Full text

Medicine, Nephrology, Pathology +10

Prognostic model for disease‐specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

Irene M. Ghobrial, Rafaël Fonseca, Morie A. Gertz et al. · British Journal of Haematology · 2006 · 142 citations · Full text

Public Health, Internal Medicine, Clinical Epidemiology +13

Discordance between serum cardiac biomarker and immunoglobulin‐free light‐chain response in patients with immunoglobulin light‐chain amyloidosis treated with immune modulatory drugs

Angela Dispenzieri, David Dingli, Shaji Kumar et al. · American Journal of Hematology · 2010 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis

Alan H. Bryce, Rhett P. Ketterling, M. A. Gertz et al. · Haematologica · 2009 · 102 citations · Full text

Medicine, Hematology, Pathology +17

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

Moritz Binder, S. Vincent Rajkumar, Rhett P. Ketterling et al. · Blood Cancer Journal · 2017 · 88 citations · Full text

Medicine, Hematology, Oncology +17